nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0764	0.0992	CbGbCtD
Arformoterol—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0502	0.0652	CbGbCtD
Arformoterol—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0336	0.0436	CbGbCtD
Arformoterol—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0316	0.041	CbGbCtD
Arformoterol—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0286	0.0371	CbGbCtD
Arformoterol—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0286	0.0371	CbGbCtD
Arformoterol—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.028	0.0363	CbGbCtD
Arformoterol—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0263	0.0341	CbGbCtD
Arformoterol—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0263	0.0341	CbGbCtD
Arformoterol—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0256	0.0332	CbGbCtD
Arformoterol—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0247	0.032	CbGbCtD
Arformoterol—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.024	0.0312	CbGbCtD
Arformoterol—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.024	0.0312	CbGbCtD
Arformoterol—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.024	0.0311	CbGbCtD
Arformoterol—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0238	0.0308	CbGbCtD
Arformoterol—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0238	0.0308	CbGbCtD
Arformoterol—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Arformoterol—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Arformoterol—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0217	0.0281	CbGbCtD
Arformoterol—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0217	0.0281	CbGbCtD
Arformoterol—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0208	0.027	CbGbCtD
Arformoterol—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0205	0.0266	CbGbCtD
Arformoterol—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0199	0.0259	CbGbCtD
Arformoterol—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0188	0.0243	CbGbCtD
Arformoterol—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0182	0.0236	CbGbCtD
Arformoterol—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.018	0.0234	CbGbCtD
Arformoterol—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.018	0.0234	CbGbCtD
Arformoterol—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0173	0.0224	CbGbCtD
Arformoterol—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0165	0.0214	CbGbCtD
Arformoterol—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0165	0.0214	CbGbCtD
Arformoterol—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000736	CcSEcCtD
Arformoterol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000735	CcSEcCtD
Arformoterol—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000735	CcSEcCtD
Arformoterol—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000734	CcSEcCtD
Arformoterol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000734	CcSEcCtD
Arformoterol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000168	0.00073	CcSEcCtD
Arformoterol—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000729	CcSEcCtD
Arformoterol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000167	0.000729	CcSEcCtD
Arformoterol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000167	0.000729	CcSEcCtD
Arformoterol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000726	CcSEcCtD
Arformoterol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000166	0.000725	CcSEcCtD
Arformoterol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000166	0.000724	CcSEcCtD
Arformoterol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000723	CcSEcCtD
Arformoterol—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000722	CcSEcCtD
Arformoterol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000166	0.000722	CcSEcCtD
Arformoterol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000166	0.000721	CcSEcCtD
Arformoterol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00072	CcSEcCtD
Arformoterol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000718	CcSEcCtD
Arformoterol—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000717	CcSEcCtD
Arformoterol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000716	CcSEcCtD
Arformoterol—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000164	0.000715	CcSEcCtD
Arformoterol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.000714	CcSEcCtD
Arformoterol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000713	CcSEcCtD
Arformoterol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000164	0.000713	CcSEcCtD
Arformoterol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.000712	CcSEcCtD
Arformoterol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000163	0.000711	CcSEcCtD
Arformoterol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000163	0.00071	CcSEcCtD
Arformoterol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000709	CcSEcCtD
Arformoterol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000708	CcSEcCtD
Arformoterol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000708	CcSEcCtD
Arformoterol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000708	CcSEcCtD
Arformoterol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000706	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000703	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000701	CcSEcCtD
Arformoterol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000161	0.0007	CcSEcCtD
Arformoterol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000161	0.0007	CcSEcCtD
Arformoterol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.0007	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000699	CcSEcCtD
Arformoterol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000699	CcSEcCtD
Arformoterol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000698	CcSEcCtD
Arformoterol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000695	CcSEcCtD
Arformoterol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000695	CcSEcCtD
Arformoterol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000694	CcSEcCtD
Arformoterol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.000694	CcSEcCtD
Arformoterol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000693	CcSEcCtD
Arformoterol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000691	CcSEcCtD
Arformoterol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.00069	CcSEcCtD
Arformoterol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.00069	CcSEcCtD
Arformoterol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.00069	CcSEcCtD
Arformoterol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000689	CcSEcCtD
Arformoterol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000688	CcSEcCtD
Arformoterol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000158	0.000687	CcSEcCtD
Arformoterol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000686	CcSEcCtD
Arformoterol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000684	CcSEcCtD
Arformoterol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000682	CcSEcCtD
Arformoterol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000682	CcSEcCtD
Arformoterol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000682	CcSEcCtD
Arformoterol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000682	CcSEcCtD
Arformoterol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000679	CcSEcCtD
Arformoterol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000679	CcSEcCtD
Arformoterol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000155	0.000677	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000677	CcSEcCtD
Arformoterol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000676	CcSEcCtD
Arformoterol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000674	CcSEcCtD
Arformoterol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000669	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000669	CcSEcCtD
Arformoterol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000667	CcSEcCtD
Arformoterol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000667	CcSEcCtD
Arformoterol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.000667	CcSEcCtD
Arformoterol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000666	CcSEcCtD
Arformoterol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000153	0.000664	CcSEcCtD
Arformoterol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000664	CcSEcCtD
Arformoterol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000664	CcSEcCtD
Arformoterol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000663	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000663	CcSEcCtD
Arformoterol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000152	0.000662	CcSEcCtD
Arformoterol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000662	CcSEcCtD
Arformoterol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00066	CcSEcCtD
Arformoterol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000656	CcSEcCtD
Arformoterol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000656	CcSEcCtD
Arformoterol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000656	CcSEcCtD
Arformoterol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000656	CcSEcCtD
Arformoterol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000655	CcSEcCtD
Arformoterol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00015	0.000655	CcSEcCtD
Arformoterol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000654	CcSEcCtD
Arformoterol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000653	CcSEcCtD
Arformoterol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00015	0.000652	CcSEcCtD
Arformoterol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00065	CcSEcCtD
Arformoterol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00065	CcSEcCtD
Arformoterol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00065	CcSEcCtD
Arformoterol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000649	CcSEcCtD
Arformoterol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000648	CcSEcCtD
Arformoterol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000646	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000646	CcSEcCtD
Arformoterol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000645	CcSEcCtD
Arformoterol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000643	CcSEcCtD
Arformoterol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000642	CcSEcCtD
Arformoterol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000642	CcSEcCtD
Arformoterol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000641	CcSEcCtD
Arformoterol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.000641	CcSEcCtD
Arformoterol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000147	0.000639	CcSEcCtD
Arformoterol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000636	CcSEcCtD
Arformoterol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000636	CcSEcCtD
Arformoterol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000635	CcSEcCtD
Arformoterol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000635	CcSEcCtD
Arformoterol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000634	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000634	CcSEcCtD
Arformoterol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000634	CcSEcCtD
Arformoterol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000633	CcSEcCtD
Arformoterol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000633	CcSEcCtD
Arformoterol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000632	CcSEcCtD
Arformoterol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000631	CcSEcCtD
Arformoterol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000629	CcSEcCtD
Arformoterol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000144	0.000629	CcSEcCtD
Arformoterol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000628	CcSEcCtD
Arformoterol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000628	CcSEcCtD
Arformoterol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000628	CcSEcCtD
Arformoterol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000627	CcSEcCtD
Arformoterol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000624	CcSEcCtD
Arformoterol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000624	CcSEcCtD
Arformoterol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000623	CcSEcCtD
Arformoterol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000623	CcSEcCtD
Arformoterol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000142	0.00062	CcSEcCtD
Arformoterol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000619	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000619	CcSEcCtD
Arformoterol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000618	CcSEcCtD
Arformoterol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000618	CcSEcCtD
Arformoterol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000614	CcSEcCtD
Arformoterol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000611	CcSEcCtD
Arformoterol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000611	CcSEcCtD
Arformoterol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00061	CcSEcCtD
Arformoterol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000607	CcSEcCtD
Arformoterol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000607	CcSEcCtD
Arformoterol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000606	CcSEcCtD
Arformoterol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000605	CcSEcCtD
Arformoterol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000605	CcSEcCtD
Arformoterol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000604	CcSEcCtD
Arformoterol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.0006	CcSEcCtD
Arformoterol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000599	CcSEcCtD
Arformoterol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000598	CcSEcCtD
Arformoterol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000598	CcSEcCtD
Arformoterol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000598	CcSEcCtD
Arformoterol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000597	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000595	CcSEcCtD
Arformoterol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000591	CcSEcCtD
Arformoterol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000588	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000586	CcSEcCtD
Arformoterol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000585	CcSEcCtD
Arformoterol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000583	CcSEcCtD
Arformoterol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000583	CcSEcCtD
Arformoterol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000583	CcSEcCtD
Arformoterol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000583	CcSEcCtD
Arformoterol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000581	CcSEcCtD
Arformoterol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000581	CcSEcCtD
Arformoterol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000581	CcSEcCtD
Arformoterol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00058	CcSEcCtD
Arformoterol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00058	CcSEcCtD
Arformoterol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000578	CcSEcCtD
Arformoterol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000575	CcSEcCtD
Arformoterol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000575	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000568	CcSEcCtD
Arformoterol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000565	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000564	CcSEcCtD
Arformoterol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000564	CcSEcCtD
Arformoterol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000563	CcSEcCtD
Arformoterol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00056	CcSEcCtD
Arformoterol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000559	CcSEcCtD
Arformoterol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000559	CcSEcCtD
Arformoterol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000556	CcSEcCtD
Arformoterol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000556	CcSEcCtD
Arformoterol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000555	CcSEcCtD
Arformoterol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000555	CcSEcCtD
Arformoterol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000554	CcSEcCtD
Arformoterol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000551	CcSEcCtD
Arformoterol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000551	CcSEcCtD
Arformoterol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.00055	CcSEcCtD
Arformoterol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000549	CcSEcCtD
Arformoterol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000547	CcSEcCtD
Arformoterol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000543	CcSEcCtD
Arformoterol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000541	CcSEcCtD
Arformoterol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000539	CcSEcCtD
Arformoterol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000539	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000538	CcSEcCtD
Arformoterol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000538	CcSEcCtD
Arformoterol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000537	CcSEcCtD
Arformoterol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000537	CcSEcCtD
Arformoterol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000537	CcSEcCtD
Arformoterol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000534	CcSEcCtD
Arformoterol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000533	CcSEcCtD
Arformoterol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000533	CcSEcCtD
Arformoterol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000527	CcSEcCtD
Arformoterol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000525	CcSEcCtD
Arformoterol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000519	CcSEcCtD
Arformoterol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000519	CcSEcCtD
Arformoterol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000519	CcSEcCtD
Arformoterol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000517	CcSEcCtD
Arformoterol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000517	CcSEcCtD
Arformoterol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000516	CcSEcCtD
Arformoterol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000514	CcSEcCtD
Arformoterol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000512	CcSEcCtD
Arformoterol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000512	CcSEcCtD
Arformoterol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.00051	CcSEcCtD
Arformoterol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000509	CcSEcCtD
Arformoterol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000507	CcSEcCtD
Arformoterol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000502	CcSEcCtD
Arformoterol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.0005	CcSEcCtD
Arformoterol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000495	CcSEcCtD
Arformoterol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000493	CcSEcCtD
Arformoterol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000493	CcSEcCtD
Arformoterol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000488	CcSEcCtD
Arformoterol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000487	CcSEcCtD
Arformoterol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000486	CcSEcCtD
Arformoterol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000484	CcSEcCtD
Arformoterol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000483	CcSEcCtD
Arformoterol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000482	CcSEcCtD
Arformoterol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000482	CcSEcCtD
Arformoterol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000481	CcSEcCtD
Arformoterol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.00048	CcSEcCtD
Arformoterol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000469	CcSEcCtD
Arformoterol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000467	CcSEcCtD
Arformoterol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000465	CcSEcCtD
Arformoterol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000463	CcSEcCtD
Arformoterol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000463	CcSEcCtD
Arformoterol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000462	CcSEcCtD
Arformoterol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00046	CcSEcCtD
Arformoterol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000459	CcSEcCtD
Arformoterol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000456	CcSEcCtD
Arformoterol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000449	CcSEcCtD
Arformoterol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000447	CcSEcCtD
Arformoterol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000447	CcSEcCtD
Arformoterol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000441	CcSEcCtD
Arformoterol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000436	CcSEcCtD
Arformoterol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000432	CcSEcCtD
Arformoterol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000432	CcSEcCtD
Arformoterol—Rash—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.000428	CcSEcCtD
Arformoterol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.000428	CcSEcCtD
Arformoterol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.79e-05	0.000427	CcSEcCtD
Arformoterol—Headache—Ritonavir—acquired immunodeficiency syndrome	9.77e-05	0.000425	CcSEcCtD
Arformoterol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000416	CcSEcCtD
Arformoterol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.47e-05	0.000412	CcSEcCtD
Arformoterol—Rash—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000412	CcSEcCtD
Arformoterol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.45e-05	0.000412	CcSEcCtD
Arformoterol—Headache—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000409	CcSEcCtD
Arformoterol—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000403	CcSEcCtD
Arformoterol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000396	CcSEcCtD
Arformoterol—Rash—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000393	CcSEcCtD
Arformoterol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000393	CcSEcCtD
Arformoterol—Headache—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.000391	CcSEcCtD
Arformoterol—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000388	CcSEcCtD
Arformoterol—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.00037	CcSEcCtD
